Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin

David I. Rosenthal, Carlos R. Becerra, Robert D. Toto, David P. Carbone, Eugene P. Frenkel

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Gadolinium (III) texaphyrin (Gd-Tex) (NSC 695238) is a potential radiation sensitizer that selectively localizes in tumors and is detectable by magnetic resonance imaging (MRI). In this single-dose phase I trial, reversible renal injury was the dose-limiting toxicity. This report details that renal injury. A single intravenous dose of Gd-Tex was followed 2 hours later by radiation therapy. The Gd-Tex dose was escalated in 13 patient cohorts. Doses ranged from 0.6 to 29.6 mg/kg. The maximum tolerated dosage (MTD) was 22.3 mg/kg. Three patients had grade II and one had grade III acute nonoliguric renal failure at the 22.3 and 29.6 mg/kg dose levels. The injury was always transient, and responded to fluid restriction and renal diet. In all patients, transient green discoloration including urine developed at doses ≥7.1 mg/kg. MRI studies demonstrated image enhancement in the liver, kidneys, and in primary and metastatic tumors in all patients receiving >5.4 mg/kg. It is important that the liver and kidneys be excluded from the radiation volume. Gd-Tex was well tolerated at doses below the MTD. It is important that the liver and kidneys be excluded from the radiation volume. We recommend that 16.7 mg/kg be used as the maximum single dose to obviate even low grade renal toxicity.

Original languageEnglish (US)
Pages (from-to)593-598
Number of pages6
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume23
Issue number6
DOIs
StatePublished - 2000

Fingerprint

Kidney
Liver
Wounds and Injuries
Magnetic Resonance Imaging
Radiation
Radiation-Sensitizing Agents
Image Enhancement
Maximum Tolerated Dose
motexafin gadolinium
Acute Kidney Injury
Neoplasms
Radiotherapy
Urine
Diet

Keywords

  • Gadolinium
  • Radiation therapy
  • Radiosensitizers
  • Renal toxicity
  • Texaphyrin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin. / Rosenthal, David I.; Becerra, Carlos R.; Toto, Robert D.; Carbone, David P.; Frenkel, Eugene P.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 23, No. 6, 2000, p. 593-598.

Research output: Contribution to journalArticle

Rosenthal, David I. ; Becerra, Carlos R. ; Toto, Robert D. ; Carbone, David P. ; Frenkel, Eugene P. / Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2000 ; Vol. 23, No. 6. pp. 593-598.
@article{c99010a11ef7415dba226afee11c3f10,
title = "Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin",
abstract = "Gadolinium (III) texaphyrin (Gd-Tex) (NSC 695238) is a potential radiation sensitizer that selectively localizes in tumors and is detectable by magnetic resonance imaging (MRI). In this single-dose phase I trial, reversible renal injury was the dose-limiting toxicity. This report details that renal injury. A single intravenous dose of Gd-Tex was followed 2 hours later by radiation therapy. The Gd-Tex dose was escalated in 13 patient cohorts. Doses ranged from 0.6 to 29.6 mg/kg. The maximum tolerated dosage (MTD) was 22.3 mg/kg. Three patients had grade II and one had grade III acute nonoliguric renal failure at the 22.3 and 29.6 mg/kg dose levels. The injury was always transient, and responded to fluid restriction and renal diet. In all patients, transient green discoloration including urine developed at doses ≥7.1 mg/kg. MRI studies demonstrated image enhancement in the liver, kidneys, and in primary and metastatic tumors in all patients receiving >5.4 mg/kg. It is important that the liver and kidneys be excluded from the radiation volume. Gd-Tex was well tolerated at doses below the MTD. It is important that the liver and kidneys be excluded from the radiation volume. We recommend that 16.7 mg/kg be used as the maximum single dose to obviate even low grade renal toxicity.",
keywords = "Gadolinium, Radiation therapy, Radiosensitizers, Renal toxicity, Texaphyrin",
author = "Rosenthal, {David I.} and Becerra, {Carlos R.} and Toto, {Robert D.} and Carbone, {David P.} and Frenkel, {Eugene P.}",
year = "2000",
doi = "10.1097/00000421-200012000-00013",
language = "English (US)",
volume = "23",
pages = "593--598",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin

AU - Rosenthal, David I.

AU - Becerra, Carlos R.

AU - Toto, Robert D.

AU - Carbone, David P.

AU - Frenkel, Eugene P.

PY - 2000

Y1 - 2000

N2 - Gadolinium (III) texaphyrin (Gd-Tex) (NSC 695238) is a potential radiation sensitizer that selectively localizes in tumors and is detectable by magnetic resonance imaging (MRI). In this single-dose phase I trial, reversible renal injury was the dose-limiting toxicity. This report details that renal injury. A single intravenous dose of Gd-Tex was followed 2 hours later by radiation therapy. The Gd-Tex dose was escalated in 13 patient cohorts. Doses ranged from 0.6 to 29.6 mg/kg. The maximum tolerated dosage (MTD) was 22.3 mg/kg. Three patients had grade II and one had grade III acute nonoliguric renal failure at the 22.3 and 29.6 mg/kg dose levels. The injury was always transient, and responded to fluid restriction and renal diet. In all patients, transient green discoloration including urine developed at doses ≥7.1 mg/kg. MRI studies demonstrated image enhancement in the liver, kidneys, and in primary and metastatic tumors in all patients receiving >5.4 mg/kg. It is important that the liver and kidneys be excluded from the radiation volume. Gd-Tex was well tolerated at doses below the MTD. It is important that the liver and kidneys be excluded from the radiation volume. We recommend that 16.7 mg/kg be used as the maximum single dose to obviate even low grade renal toxicity.

AB - Gadolinium (III) texaphyrin (Gd-Tex) (NSC 695238) is a potential radiation sensitizer that selectively localizes in tumors and is detectable by magnetic resonance imaging (MRI). In this single-dose phase I trial, reversible renal injury was the dose-limiting toxicity. This report details that renal injury. A single intravenous dose of Gd-Tex was followed 2 hours later by radiation therapy. The Gd-Tex dose was escalated in 13 patient cohorts. Doses ranged from 0.6 to 29.6 mg/kg. The maximum tolerated dosage (MTD) was 22.3 mg/kg. Three patients had grade II and one had grade III acute nonoliguric renal failure at the 22.3 and 29.6 mg/kg dose levels. The injury was always transient, and responded to fluid restriction and renal diet. In all patients, transient green discoloration including urine developed at doses ≥7.1 mg/kg. MRI studies demonstrated image enhancement in the liver, kidneys, and in primary and metastatic tumors in all patients receiving >5.4 mg/kg. It is important that the liver and kidneys be excluded from the radiation volume. Gd-Tex was well tolerated at doses below the MTD. It is important that the liver and kidneys be excluded from the radiation volume. We recommend that 16.7 mg/kg be used as the maximum single dose to obviate even low grade renal toxicity.

KW - Gadolinium

KW - Radiation therapy

KW - Radiosensitizers

KW - Renal toxicity

KW - Texaphyrin

UR - http://www.scopus.com/inward/record.url?scp=0034443675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034443675&partnerID=8YFLogxK

U2 - 10.1097/00000421-200012000-00013

DO - 10.1097/00000421-200012000-00013

M3 - Article

C2 - 11202804

AN - SCOPUS:0034443675

VL - 23

SP - 593

EP - 598

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 6

ER -